Status:
UNKNOWN
Collection of Gastrointestinal Malignant and Non-malignant Human Samples
Lead Sponsor:
University of Texas at Austin
Conditions:
Inflammatory Bowel Diseases
Colo-rectal Cancer
Eligibility:
All Genders
18-99 years
Brief Summary
To collect human tissue, blood, and fecal samples from patients suffering from Inflammatory Bowel Disease and Colorectal Cancer. The samples will be used to establish biomimetic human organ-on-a-chip ...
Detailed Description
The purpose of the proposed research is to collect tissue, blood and fecal samples from patients undergoing standard of care for their gastrointestinal disease, including Inflammatory Bowel Disease (I...
Eligibility Criteria
Inclusion
- Biopsy-proven colorectal cancer scheduled to have surgical resection of primary site, at participating and approved facilities. Since it is standard clinical care to resect certain suspicious gastrointestinal masses without a pre-existing biopsy, patients who are undergoing resections for highly suspicious masses believed to be cancer, may be consented.
- Diagnosed with Inflammatory Bowel Disease (IBD) or Crohn's Disease (CD), scheduled to have biopsy and/or fecal collection.
- scheduled to have a colonoscopy as part of routine screening.
- 18 years old.
- Ability to understand and willingness to sign a written informed consent document.
Exclusion
- The study will not exclude potential subjects from participation on the basis of ethnic origin or gender. Subjects recruited will include men, women, and all ethnic origins, provided they meet all inclusion criteria listed above.
Key Trial Info
Start Date :
July 13 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03415919
Start Date
July 13 2018
End Date
July 1 2022
Last Update
June 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas
Austin, Texas, United States, 78712